SignalCorporate
Preclinical CRO - Global Market Size, Share, Trends, and Growth Forecasts, 2026-2031 | AI Adoption and Outsourcing Propel Revenue to USD 11.74 Billion
AI adoption and outsourcing drive preclinical CRO revenue to USD 11.74 billion by 2031.
Context
What happened: ResearchAndMarkets.com added a preclinical CRO market report covering 2026 to 2031, projecting growth from USD 8.20 billion to USD 11.74 billion.
Key numbers: USD 8.20 billion in 2026; USD 11.74 billion by 2031; 7.45% CAGR; toxicology 40.55% of 2025 market; safety pharmacology 12.25% CAGR; North America 45.13% of 2025 revenue;
Why it matters: The report attributes growth to rising pharmaceutical R&D spending, expanding drug pipelines, and outsourcing, while citing data standardization problems such as SEND validation errors affecting 38% of IND submissions in 2024.
Market: +0.7% today ($29.64), +21.7% YTD, 0.4x vol — as of 18:03 UTC
Coverage: 3 outlets in 24h
What changed
ResearchAndMarkets.com added a preclinical CRO market report covering 2026 to 2031, projecting growth from USD 8.20 billion to USD 11.74 billion.
Why it matters
The report attributes growth to rising pharmaceutical R&D spending, expanding drug pipelines, and outsourcing, while citing data standardization problems such as SEND validation errors affecting 38% of IND submissions in 2024.
Market: +0.7% today ($29.64), +21.7% YTD, 0.4x vol — as of 18:03 UTC